Sign in
Not yet recruitingNo phase

Iron through a vein for anemia in women around childbirth

Looks at intravenous iron for anemic women before and after giving birth.

Key facts

Who runs it
Johann Wolfgang Goethe University Hospital
Where
Germany2 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Impact of Iron Supplementation During Pregnancy
Status
Not yet recruiting
People taking part
800 people, planned
Started
1 Oct 2026
Expected to end
31 Dec 2028
Type of study
Observational
Treatments tested
  • Iron
Record updated
11 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women. It studies whether iron given through a vein improves blood levels and quality of life before and after giving birth.

Age
18 Years and older
Sex
Female
Earlier treatment
People who had iron given through a vein within 3 months before enrolment cannot join.

Main reasons for not taking part

  • Thalassemia or sickle cell disease
  • Aplastic anemia or hemochromatosis
  • Long-term inflammatory diseases linked to anemia of chronic disease
  • Severe kidney failure (severe renal insufficiency)
  • Iron given through a vein within 3 months before enrolment

This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnancy

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Pregnancy

Who cannot take part

  • Intravenous iron administration within 3 months prior to enrollment
  • Sickle cell disease
  • Chronic inflammatory diseases associated with anemia of chronic disease
  • Severe renal insufficiency
  • Thalassemia
  • Aplastic anemia
  • Hemochromatosis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

During pregnancy, iron deficiency is the most common cause of anemia. Anemia is very common during pregnancy and after childbirth. Around half of pregnant women develop anemia, and after delivery, up to 85% of women may be affected.

Read full original descriptionShow less

This study looks at whether iron given through a vein (intravenous iron) can improve blood levels and how women feel and function in everyday life before and after giving birth.

Treatments tested

  • Iron

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Iron Supplementation on Haemoglobin Levels and Quality-of-life in Iron-deficient (Anaemic) Women Before and After Delivery
Plain-language title
Iron through a vein for anemia in women around childbirthGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
11 September 2026